Start here · since 1996

Psychedelics Guide

More than 500 articles organized by substance and topic: psilocybin, LSD, ayahuasca, DMT, MDMA, mescaline and harm reduction. Rigorous information, without fear and without propaganda.

Featured articles

Explore the largest archive on psychoactive substances, published since 1996

US Psychedelic Helpline: Insights from 25,419 Interactions

A Science Advances paper details 25,419 contacts with the Fireside Project (2021-2026), primarily regarding psilocybin and trip support. Among interactions with recorded history, 2.4% mentioned schizophrenia. The data reflects only those who reached out.

Persistent difficulties after psychedelics or meditation: Emory publishes a protocol for a 1,600-person study

A team led by Emory University has posted on medRxiv the protocol for an observational study that will follow, for one year, people who attribute persistent difficulties to psychedelics or meditation. It is a research plan with no data. The sample is deliberately recruited among affected people, so it is not designed to estimate how often these problems occur.

Mind & Spirit

Inspiring reads for open minds

From our readers

Articles chosen by our community of readers

Send us your story and get featured on our homepage

Cannabis, Anxiety, and Self-Regulation: Mental Space or Escapism?

Self-control versus hyperarousal and distress: what role is attributed to cannabis, and why should we approach these claims with a critical eye?

Recreational vs. Clinical Ketamine: Uses and Harm Reduction

What separates supervised clinical ketamine from recreational use: mechanisms, EMA and FDA-approved indications, bladder and kidney risks, and harm reduction.

Tramadol: The Atypical Opioid That Doesn’t Act Like One

What is tramadol, how does it affect opioids, serotonin, and norepinephrine, and why its interactions and seizure risk demand caution.

Addiction, Spirituality, and Western Science

by Stanislav Grof

Stanislav Grof, M.D., Ph.D., is a psychiatrist with more than 30 years of research into non-ordinary states of consciousness induced by psychedelic substances and various drug-free techniques. He was born in Prague, Czechoslovakia, where he also did his scientific training—an M.D. at the Charles University School of Medicine and a Ph.D. at the Czechoslovak Academy of Sciences. His first research on the clinical use of psychedelic drugs was carried out at the Prague Psychiatric Research Institute, where he was principal investigator of a program on the heuristic and therapeutic potential of LSD and other psychedelic substances. In 1967 he was invited as a research and clinical fellow by Johns Hopkins University in Baltimore, MD. After two years he decided to stay in the United States and continue his research as Chief of Psychiatric Research in Maryland and as an assistant professor of psychiatry at the Henry Phipps Clinic of Johns Hopkins University. In 1973 he was invited by the Esalen Institute in Big Sur, California, where he lived until 1987 as a scholar in residence, writing, giving seminars and courses, and developing, with his wife Christina, Holotropic Breathwork, an innovative form of experiential psychiatry. He was a member of the Institute's Board of Trustees.

He currently lives in Mill Valley, CA, leading practical seminars for professionals in holotropic breathwork and transpersonal psychology (Grof Transpersonal Training) and giving courses and seminars around the world. He is one of the founders and leading theorists of transpersonal psychology and the founding president of the International Transpersonal Association. Through this association he has organized international conferences in the United States, India, and Australia.

News

The latest from the psychedelic world

Latest articles

Browse our most recent articles